T1	p 37 43	clinic
T2	p 77 108	treated hypertensive patients .
T3	p 155 192	Project ( PPP ) -- Hypertension study
T4	p 275 311	hypertensive patients receiving drug
T5	p 485 499	and ambulatory
T6	p 545 558	hypertensives
T7	p 562 578	chronic , stable
T8	p 596 603	therapy
T9	p 673 688	Project ( PPP )
T10	p 785 800	people with one
T11	p 837 965	. Fifteen Italian hypertension units studied 142 hypertensive patients ( 76 men , 66 women ; mean age 59 +/- 5.9 years ) treated
T12	p 981 997	antihypertensive
T13	p 1004 1022	: 71 patients were
T14	p 1059 1070	as controls
T15	p 1077 1104	patients underwent a clinic
T16	p 1348 1372	and untreated subjects .
T17	i 17 33	low-dose aspirin
T18	i 48 58	ambulatory
T19	i 109 122	Collaborative
T20	i 195 207	Nonsteroidal
T21	i 262 263	)
T22	i 351 367	low-dose aspirin
T23	i 452 474	aspirin ( 100 mg/day )
T24	i 596 605	therapy .
T25	i 761 781	aspirin or vitamin E
T26	i 981 1003	antihypertensive drugs
T27	i 1037 1051	aspirin and 71
T28	i 1098 1107	clinic BP
T29	i 1165 1178	ambulatory BP
T30	i 1226 1245	aspirin treatment .
T31	i 1414 1421	aspirin
T32	i 1543 1551	deltaDBP
T33	i 1681 1688	aspirin
T34	i 1724 1728	drug
T35	i 1737 1803	( angiotensin converting enzyme inhibitors and calcium antagonists
T36	i 1906 1922	low-dose aspirin
T37	o 37 73	clinic and ambulatory blood pressure
T38	o 242 263	blood pressure ( BP )
T39	o 478 541	clinic and ambulatory systolic ( SBP ) and diastolic ( DBP ) BP
T40	o 809 828	cardiovascular risk
T41	o 1105 1118	BP evaluation
T42	o 1160 1189	24-h ambulatory BP monitoring
T43	o 1285 1303	clinic SBP and DBP
T44	o 1373 1395	Ambulatory SBP and DBP
T45	o 1605 1612	pattern
T46	o 1926 1936	BP control